Transcript Business Communication

The Launch of
RheumaKnowledgy.com
RheumNow.com
Two websites dedicated to online medical education
RheumNow
RheumNow: Mission Statement
Daily news, information and Social Media for the Rheum
•To be the rheumatologists preferred online source for
daily and facile access to news, information, practice
guides on the diagnosis and care of rheumatologic and
autoimmune diseases
•To be the patients preferred online source for expert
opinion, news and information on “arthritis”
•A Premium Sources of Useful/Credible Content
RheumNow
RheumNow :The Team
• Editor: John J. Cush, MD
– Academic, educator, leader & KOL (key opinion leader)
– 130+ medical articles published, 2 books, 12 chapters, Editor of the
ACR Drug Safety Quarterly x 4 yrs; Associate Editor Seminars in
Arthritis & Rheumatism; Journal of Rheumatology
•
•
•
•
Project Manager & Web Master
Managing Editor
Sales director and Syndicator
Associate Editor: Kathryn Dao & Catalina Orozco
– Experts in content generation and editting
• Reporters/Staff – 5-6 Rheumatologists
RheumNow
The Contributors
• Editor-in-chief: J Cush
• Associate Editors: K. Dao; C. Orozco (later A Kavanaugh)
• KOL “Faculty” Commentaries (Mon, Thurs)
– Commentaries, perspectives, practice guides
– 20 faculty – each providing >2 per year
• Written 800-1500 words + Podcast and Videocast < 5 minutes
• Reporters: 5-6 needed
– Social media engaged, >3 yrs beyond fellowship
– 2-4 tweets and news per week
RheumNow
The Content
• Useful/Credible Content delivered to Rheums & subscribers 5 days/wk & 50 wks/year
– 5 “feeds” per day: Twitter, Linked-in, Google+, FB, SlideShare
– 5 Rheum News /info/publications per day
• Tweets expanded, Journal articles, news, CDC, RSS feeds
• Updates from Meetings: ACR, EULAR, SOTA, RWCS, NYU, Congress, FDA
– 1 feature per day
•
•
•
•
KOL Blog/Commentary – 2 per week, Mon & Wed
RCT Tuesday
Drug Safety Bulletin – Thursday
Friday: Practice of medicine, Slide of week
– Smarter-Side of Rheum: Daily Slide/Table/Quote
ADVERTISING
Know-it-Now
RheumNow
My Folder
BackLog
RA
SLE
PsA
SpA/AS
OA
FM
Gout
Biologics
MTX
DMARDs
Daily Tweets
News Now
Schizophrenia pts are at reduce risk for
#rheumatoid arthritis.Proof that God only
gives us what we can handle
http://buff.ly/1hnrPMJ
Colcrys finally goes generic….
Free Online Textbook
890 Finnish #RA patients - 91% Rx w/
DMARDs, 21% Biologics; 52% achieved
remission & 70% low activity w/ current Rxs
http://buff.ly/1hAmscj
ADVERTISING
Xeljanz: its MOA is still puzzle-Its not a
biologic. Does inhibit JAK1/3 w/ inhib of
IL7,15, 21, IL6. Its toxicity profile same as
Actemra
Mayo study shows diagnostic value of Dual
Energy CT (DECT) scans are cool advance in
diagnosing gout & quantifying urate
depositio… http://buff.ly/1pKXl9n
Jack wants
a survey
box too
Smarter Side of Rheum
Daily Feature
One-third of patientss with neuropathic
(Charco) arthritis have no cause: Others
causes: diabetes, syphilis, syringomyelia, CPPD
KOL Blogs
ADVERTISING
Know-it-Now
RheumNow
My Folder
BackLog
RA
SLE
PsA
SpA/AS
OA
FM
Gout
Biologics
MTX
DMARDs
Enbrel
Daily Tweets
News Now
Schizophrenia pts are at reduce risk for
#rheumatoid arthritis.Proof that God only
gives us what we can handle
http://buff.ly/1hnrPMJ
Colcrys finally goes generic….
One-third of patientss with neuropathic
(Charco) arthritis have no cause: Others
causes: diabetes, syphilis, syringomyelia, CPPD
890 Finnish #RA patients - 91% Rx w/
DMARDs, 21% Biologics; 52% achieved
remission & 70% low activity w/ current Rxs
http://buff.ly/1hAmscj
Xeljanz: its MOA is still puzzle-Its not a
biologic. Does inhibit JAK1/3 w/ inhib of
IL7,15, 21, IL6. Its toxicity profile same as
Actemra
Mayo study shows diagnostic value of Dual
Energy CT (DECT) scans are cool advance in
diagnosing gout & quantifying urate
depositio… http://buff.ly/1pKXl9n
Smarter Side of Rheum
Daily Feature
Free Online Textbook
ADVERTISING
KOL Blogs
Actemra
Humira
Benylsta
Orencia
Xeljanz
RheumNow
The Programming Needs
•
•
•
•
•
•
Develop work teams, assignments
Managing Editor
Document management for daily uploads
Automate uploads to become Backlog entries/database
How much Advertising space
Hosting, space, server, cost demands